$BOT

RoboStrategy, Inc. Updates Net Asset Value as of September 30, 2026

RoboStrategy, Inc. (Nasdaq: BOT) reported its net asset value per share as of September 30, 2026, at $11.35, a 0.3569% increase from August 31, 2026. The fund's total net assets applicable to common shares were $277,663,100.44. RoboStrategy focuses on investing in private robotics and physical AI companies.

Original reporting
Published Oct 5, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 5, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$BOT
Neutral
medium confidence
Mentioned
$BOT
Relevance
4/10
AlphAI data visualization · based on globenewswire.com
Decision brief

The 30-second read

$BOTNeutralLow
01

Why it matters

The NAV increase is modest and does not introduce new material information beyond the fund's regular reporting schedule.

02

Market read

The announcement is a routine NAV update with limited trading relevance.

03

What to watch

Potential future NAV changes could be driven by performance of underlying private robotics companies, which remain opaque.

Relevance 4/10Novelty 3/10Timing: today

Background

RoboStrategy, Inc. (BOT) is a Nasdaq‑listed closed‑end fund that provides exposure to private robotics and physical AI companies. NAV updates are routine disclosures for such funds.

Company-level read

Ticker impact

$BOTNeutralMedium confidence
Context

RoboStrategy, Inc. disclosed its updated NAV per share of $11.35 as of September 30, 2026, a 0.3569% increase from the prior month.

Expected impact

likely neutral to slight upward pressure as the market prices the small NAV increase.

Evidence & confidence

The fund's NAV rose marginally; such incremental changes rarely drive significant price moves.

Market effects

Minimal impact on the broader robotics and AI sector; the NAV reflects existing holdings.

No discernible regional effect.

Limited relevance beyond investors in the closed‑end fund.

Counterpoint

Investors may view the modest NAV rise as insufficient to justify buying the fund at current levels.

Key entities

  • RoboStrategy, Inc.

    Closed‑end fund focused on private robotics and AI companies.

Related articles

$BOTMedAI 8/10

RoboStrategy, Inc. Raises Approximately $16.0 Million Through Private Share Issuances, Including $10.0 Million Investment by CEO Andrew Kang

RoboStrategy, Inc. (Nasdaq: BOT) said it completed private share issuances from July 7 to July 14, 2026, issuing 450,684 shares at a weighted average price of about $35.50 to raise about $16.0 million gross. CEO Andrew Kang invested about $10.0 million for 272,405 shares at $36.71. No fees were paid; the fund plans a resale registration statement.

$CMPXMedAI 8/10

Compass Therapeutics publishes tovecimig trial results in JCO

Compass Therapeutics (NASDAQ:CMPX) published Phase 2/3 trial results for tovecimig in the Journal of Clinical Oncology. The study met primary and secondary endpoints, showing improved response rates and progression-free survival in advanced biliary tract cancer patients compared to paclitaxel alone. However, overall survival showed no significant difference, and adverse events were higher in the combination arm. Tovecimig remains investigational.